Last reviewed · How we verify
Inflammatory profile
At a glance
| Generic name | Inflammatory profile |
|---|---|
| Also known as | C-reactive protein (PCR), Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM), Complement (C3) |
| Sponsor | Monica Levy Andersen |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease (NA)
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
- Evaluation of Intravenous Sodium Valproate on Interleukin-6 Levels in Patients With TMJ Disc Displacement (PHASE2)
- Pro- and Anti-inflammatory Cytokines in PCOS
- Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE) (NA)
- Evaluation of Implantoplasty in the Treatment of Peri-Implantitis. (NA)
- Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inflammatory profile CI brief — competitive landscape report
- Inflammatory profile updates RSS · CI watch RSS
- Monica Levy Andersen portfolio CI